ORG 39970
Latest Information Update: 20 Oct 2009
At a glance
- Originator Organon
- Class
- Mechanism of Action Testosterone congener stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Andropause; Female genital diseases
Most Recent Events
- 19 Nov 2007 Organon has been acquired by Schering-Plough
- 28 Oct 2005 Phase-II clinical trials in Andropause in Netherlands (unspecified route)